おかえりなさい
Click “ログイン” to agree to Cointime’s 利用規約 and acknowledge that Cointime’s プライバシーポリシー applies to you.
アカウント登録
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">利用規約</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">プライバシーポリシー</a> applies to you.
siteでログインする
siteで登録する
あなたのメールアドレス
受信トレイを確認する
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Nectar
company
About
Nectar builds a comprehensive, vertically integrated allergy healthcare platform leveraging data and clinical research.
- New York,New York,United States
- 11 - 50
- https://www.mynectar.com
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- $16.50M
- Industries
- Clinical Trials,Health Care,Health Diagnostics,Medical,Pharmaceutical,Therapeutics
- Founded date
- Jan 1, 2021
- Number Of Employee
- 11 - 50
- Operating Status
- Active
- Legal Name
- Nectar Life Sciences, Inc.
- Also Known As
- Nectar Life Sciences
Nectar builds a comprehensive, vertically integrated allergy healthcare platform leveraging data and clinical research. The company was founded in 2021 and is headquartered in New York.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$24.50M
Nectar has raised a total of
$24.50M
in funding over 2 rounds. Their latest funding was raised on
Dec 20, 2022 from a Series A round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Dec 20, 2022 | Series A | $16.50M | 3 |
|
— | Detail |
| Mar 16, 2022 | Seed | $8M | 2 |
Juxtapose
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
2
3
Nectar is funded by 3 investors.
Harmony Partners
and Juxtapose
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
Yes | Series A |
|
Juxtapose
|
— | Series A |
Obvious Ventures
|
— | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
